Press Release

Date: August 20, 2026 National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, C-1, Block G, 20th Floor, P.J. Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai – 400 051 Mumbai - 400001. NSE Scrip Symbol: MANIPALHOS BSE Scrip Code: 544847 Subject: Press Release and Investor Presentation for the Earnings Conference Call with Analysts and Investors of Manipal Health Enterprises Limited (the “Company”) Dear Sir/Ma’am, Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), please find enclosed the Press Release and Investor Presentation in connection with the earnings conference call scheduled to be held tomorrow, i.e., August 21, 2026, to discuss the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter ended June 30, 2026. The above information is also hosted on the website of the Company at: https://www.manipalhospitals.com This intimation is being submitted for your information and records. Kindly take the same on record. Thank you. For Manipal Health Enterprises Limited (formerly known as Manipal Health Enterprises Private Limited) Sathish K R Company Secretary and Compliance Officer Membership No.: A15203 MHE-Public Manipal Hospitals Delivers 38.1% Revenue Growth and 26.4% EBITDA Growth in Q1 FY27 Patient-led growth and specialty care momentum support performance across the network Bengaluru, Karnataka, August 20, 2026: Manipal Health Enterprises Limited (Manipal Hospitals), India’s largest pan-India multi-specialty hospital networks by bed capacity, today announced its financial results for the quarter ended June 30, 2026 (Q1 FY27), marking its first results announcement following its listing on August 5, 2026. The company delivered a strong operating performance during the quarter, supported by sustained patient demand, growth in high-acuity specialties and capacity absorption. Improving occupancy and operating efficiencies further strengthened the performance of the expanded network. Operating Performance Revenue from operations stood at ₹ 3,091 crore in Q1 FY27, registering 38.1% year-on-year growth, while EBITDA stood at ₹ 749 crore reflecting year-on-year growth of 26.4%. Excluding one-off gain of ₹ 15 crore in Q1 FY26, EBITDA growth was 29.7% year-on-year, reflecting continued operating improvement. Inpatient and outpatient volumes grew 38.8% and 26.0%, respectively, during the quarter, while occupancy improved by 290 basis points year-on-year to 65.0% as the network continued to absorb recently added capacity. PAT stood at ₹ 243 crore during Q1FY27. Excluding ₹ 89 crore of post-tax interest on the NCD raised for the Sahyadri acquisition, adjusted PAT grew 30.9% year-on-year. ARPOB, excluding Sahyadri, stood at ₹ 77,200 per day, up 8.7% year-on-year, reflecting improved revenue intensity across the existing network. Sahyadri Integration Supports Growth Sahyadri Hospitals continued to contribute to the network’s performance during the quarter, with its integration progressing across clinical and operational functions. Sahyadri recorded 12.8%* revenue growth and 18.7%* EBITDA growth year-on-year, supported by higher ARPOB and improved operating efficiency. The integration is expected to unlock further benefits through greater clinical integration, shared capabilities and operating scale. High-Acuity Specialties Continue to Drive Momentum Gross inpatient revenue from CONGO-R specialties grew 45% year-on-year, with the specialty mix increasing to 65.4%, highlighting continued demand for complex care. Oncology and Orthopedics were key growth drivers, recording inpatient revenue growth of 62% and 49%, respectively, supported by broad-based momentum across the CONGO-R portfolio. * Q1FY26 as per erstwhile management reporting since Sahyadri was acquired on October 3, 2025 Performance Highlights: Particulars (₹ Cr) Q1 FY2027 Q1 FY2026* YoY Q4 FY2026 QoQ Revenue from 3,091 2,238 38.1% 2,882 7.2% Operations EBITDA 749 593(1) 26.4% 702 6.6% EBITDA Margin % 24.2% 26.5% (230) bps 24.4% (20) bps PAT 243(2) 254 (4.2)% 187 30.5% PAT Margin % 7.9% 11.4% (350) bps 6.5% 140 bps ARPOB (₹/day) 71,500(3) 71,000 0.7% 68,500 4.4% Occupancy % 65.0% 62.1% 290 bps 64.9% 10 bps (1) Excluding a one-off gain of ₹15 crore in Q1 FY26, adjusted EBITDA was ₹578 crore, with Q1 FY27 adjusted EBITDA growth of 29.7% YoY. (2) Excluding ₹89 crore of post-tax interest on the Sahyadri acquisition NCD, Q1 FY27 adjusted PAT was ₹332 crore, up 30.9% YoY. (3) Excluding Sahyadri, Q1 FY27 ARPOB was ₹77,200 per day, representing growth of 8.7% YoY. * Sahyadri was acquired on October 3,2025 and hence Q1FY26 numbers do not include Sahyadri. Commenting on the Q1 FY27 performance, Dilip Jose, Managing Director & CEO, Manipal Hospitals, said: “Q1 FY27 marks an important milestone for Manipal Hospitals as our first quarter as a listed company. Our performance this quarter reflects the strength of our Pan-India network, sustained patient demand and continued growth in high-acuity specialties. We remained focused on absorbing added capacity while maintaining clinical quality, patient outcomes and operational discipline. The integration of Sahyadri Hospitals remains a key priority as we unlock the benefits of a larger network and greater operating scale. Our IPO provides greater flexibility to invest in capacity, technology and clinical excellence while maintaining disciplined capital allocation. As we enter this next phase, we remain focused on expanding access, strengthening clinical outcomes, improving efficiency and building a more integrated and sustainable healthcare platform.” About Manipal Hospitals: Manipal Hospitals is one of India’s leading integrated healthcare providers serving ~ 8 million patients annually, focussed on providing accessible, high-quality healthcare services. Manipal Hospitals integrated network today has a Pan-India footprint of 50 hospitals with over 13,400 licensed beds across 14 States & Union Territories. The network is India’s largest multispecialty hospital network by bed capacity, supported by a talented pool of 11,000+ doctors and an employee strength of over 25,000. With a commitment to provide patient-centric care, Manipal Hospitals combines clinical expertise with advanced technology, research and innovation to serve a multitude of patients across the globe. Its continued focus on clinical quality and operational excellence is reflected in its NABH accreditation, with several of its hospitals also accredited by NABL and recognised for its excellence in nursing and emergency care. For more information, please visit - https://www.manipalhospitals.com/ 246 7 86 74 76 70 222 8 198 96 135 115 230 Manipal Health Enterprises Limited 242 4 242 123 242 212 Earnings Update: Q1 FY27 Disclaimer This presentation is issued by Manipal Health Enterprises Limited (the “Company”) for general information purposes only, without regards to the specific objectives, financial situation 87 or requirements of any particular person. This presentation may not be copied, published, distributed or transmitted, in whole or in part, for any purpose, and should not be construed as legal, tax, investment or other advice. This presentation does not constitute a prospectus, placement document, offering circular or offering memorandum and is not an offer or invitation or recommendation or solicitation 247 230 or inducement to buy or sell any equity shares or other securities of the Company or its Subsidiaries. This presentation shall not form the basis of, or be relied on, in connection with, 248 230 any contract or investment decision in relation to any securities. 254 230 Unless otherwise stated, the information contained herein is based on management information and estimates. The information contained herein is only current as of the date specified herein, has not been independently verified and may be subject [Showing first 8,000 characters — download PDF for full document]